Woodline Partners’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,941
| Closed | -$90.7K | – | 973 |
|
|
2024
Q4 | $90.7K | Hold |
8,941
| – | – | ﹤0.01% | 914 |
|
|
2024
Q3 | $111K | Hold |
8,941
| – | – | ﹤0.01% | 581 |
|
|
2024
Q2 | $116K | Hold |
8,941
| – | – | ﹤0.01% | 538 |
|
|
2024
Q1 | $203K | Buy |
8,941
+1,160
| +15% | +$26.3K | ﹤0.01% | 513 |
|
|
2023
Q4 | $101K | Sell |
7,781
-1,160
| -13% | -$15.1K | ﹤0.01% | 461 |
|
|
2023
Q3 | $180K | Buy |
+8,941
| New | +$180K | ﹤0.01% | 559 |
|
|
2023
Q1 | – | Sell |
-88,326
| Closed | -$4.5M | – | 708 |
|
|
2022
Q4 | $4.5M | Sell |
88,326
-12,558
| -12% | -$640K | 0.06% | 334 |
|
|
2022
Q3 | $8.26M | Buy |
+100,884
| New | +$8.26M | 0.12% | 219 |
|
|
2020
Q3 | – | Sell |
-30,882
| Closed | -$8.77M | – | 196 |
|
|
2020
Q2 | $8.77M | Buy |
+30,882
| New | +$8.77M | 0.35% | 79 |
|
|
2020
Q1 | – | Sell |
-2,546
| Closed | -$732K | – | 157 |
|
|
2019
Q4 | $732K | Buy |
+2,546
| New | +$732K | 0.03% | 105 |
|